Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Enhanced short-chain fatty acids production from waste activated sludge by combining calcium peroxide with free ammonia pretreatment.

Wang D, Shuai K, Xu Q, Liu X, Li Y, Liu Y, Wang Q, Li X, Zeng G, Yang Q.

Bioresour Technol. 2018 Aug;262:114-123. doi: 10.1016/j.biortech.2018.04.081. Epub 2018 Apr 24.

PMID:
29702420
2.

Aquaporin 9 is down-regulated in hepatocellular carcinoma and its over-expression suppresses hepatoma cell invasion through inhibiting epithelial-to-mesenchymal transition.

Zhang WG, Li CF, Liu M, Chen XF, Shuai K, Kong X, Lv L, Mei ZC.

Cancer Lett. 2016 Aug 10;378(2):111-9. doi: 10.1016/j.canlet.2016.05.021. Epub 2016 May 20.

PMID:
27216981
3.

PIAS1 regulates breast tumorigenesis through selective epigenetic gene silencing.

Liu B, Tahk S, Yee KM, Yang R, Yang Y, Mackie R, Hsu C, Chernishof V, O'Brien N, Jin Y, Fan G, Lane TF, Rao J, Slamon D, Shuai K.

PLoS One. 2014 Feb 24;9(2):e89464. doi: 10.1371/journal.pone.0089464. eCollection 2014.

4.

PIAS1 SUMO ligase regulates the self-renewal and differentiation of hematopoietic stem cells.

Liu B, Yee KM, Tahk S, Mackie R, Hsu C, Shuai K.

EMBO J. 2014 Jan 13;33(2):101-13. doi: 10.1002/embj.201283326. Epub 2013 Dec 15.

5.

Pillars article: Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science. 1992. 257: 809-813.

Schindler C, Shuai K, Prezioso VR, Darnell JE Jr.

J Immunol. 2011 Dec 1;187(11):5489-94. No abstract available.

6.

In vitro and in vivo evaluation of SLA titanium surfaces with further alkali or hydrogen peroxide and heat treatment.

Zhang EW, Wang YB, Shuai KG, Gao F, Bai YJ, Cheng Y, Xiong XL, Zheng YF, Wei SC.

Biomed Mater. 2011 Apr;6(2):025001. doi: 10.1088/1748-6041/6/2/025001. Epub 2011 Feb 4.

PMID:
21293055
7.

The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression.

Liu B, Tahk S, Yee KM, Fan G, Shuai K.

Science. 2010 Oct 22;330(6003):521-5. doi: 10.1126/science.1193787.

8.

Summon SUMO to wrestle with inflammation.

Liu B, Shuai K.

Mol Cell. 2009 Sep 24;35(6):731-2. doi: 10.1016/j.molcel.2009.09.002.

9.

Targeting the PIAS1 SUMO ligase pathway to control inflammation.

Liu B, Shuai K.

Trends Pharmacol Sci. 2008 Oct;29(10):505-9. doi: 10.1016/j.tips.2008.07.008. Epub 2008 Aug 26.

10.

Regulation of the sumoylation system in gene expression.

Liu B, Shuai K.

Curr Opin Cell Biol. 2008 Jun;20(3):288-93. doi: 10.1016/j.ceb.2008.03.014. Epub 2008 May 28. Review.

11.

Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.

Dawlaty MM, Malureanu L, Jeganathan KB, Kao E, Sustmann C, Tahk S, Shuai K, Grosschedl R, van Deursen JM.

Cell. 2008 Apr 4;133(1):103-15. doi: 10.1016/j.cell.2008.01.045.

12.

PIASx is a MEF2 SUMO E3 ligase that promotes postsynaptic dendritic morphogenesis.

Shalizi A, Bilimoria PM, Stegmüller J, Gaudillière B, Yang Y, Shuai K, Bonni A.

J Neurosci. 2007 Sep 12;27(37):10037-46.

13.

Control of specificity and magnitude of NF-kappa B and STAT1-mediated gene activation through PIASy and PIAS1 cooperation.

Tahk S, Liu B, Chernishof V, Wong KA, Wu H, Shuai K.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11643-8. Epub 2007 Jul 2.

14.

Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.

Liu B, Yang Y, Chernishof V, Loo RR, Jang H, Tahk S, Yang R, Mink S, Shultz D, Bellone CJ, Loo JA, Shuai K.

Cell. 2007 Jun 1;129(5):903-14.

15.

[Expression of minichromosome maintenance protein 6 in craniopharyngioma and its correlation with prognosis].

Xu JG, You C, Wang XJ, Shuai KG, Wang XS.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Jan;38(1):64-7. Chinese.

PMID:
17294730
16.

Regulation of protein tyrosine phosphatase 1B by sumoylation.

Dadke S, Cotteret S, Yip SC, Jaffer ZM, Haj F, Ivanov A, Rauscher F 3rd, Shuai K, Ng T, Neel BG, Chernoff J.

Nat Cell Biol. 2007 Jan;9(1):80-5. Epub 2006 Dec 10.

PMID:
17159996
17.

UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity.

Malakhova OA, Kim KI, Luo JK, Zou W, Kumar KG, Fuchs SY, Shuai K, Zhang DE.

EMBO J. 2006 Jun 7;25(11):2358-67. Epub 2006 May 18.

18.

Regulation of cytokine signaling pathways by PIAS proteins.

Shuai K.

Cell Res. 2006 Feb;16(2):196-202. Review.

19.

Regulation of gene-activation pathways by PIAS proteins in the immune system.

Shuai K, Liu B.

Nat Rev Immunol. 2005 Aug;5(8):593-605. Review.

PMID:
16056253
20.

DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling.

Fan G, Martinowich K, Chin MH, He F, Fouse SD, Hutnick L, Hattori D, Ge W, Shen Y, Wu H, ten Hoeve J, Shuai K, Sun YE.

Development. 2005 Aug;132(15):3345-56.

21.

[Therapeutic effect of far lateral approach on the lesions located ventral to cranial-cervical junction].

Wu B, You C, Cai BW, He M, Shuai KG.

Zhonghua Wai Ke Za Zhi. 2005 May 1;43(9):612-5. Chinese.

PMID:
15938939
22.

Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle.

Zhong M, Henriksen MA, Takeuchi K, Schaefer O, Liu B, ten Hoeve J, Ren Z, Mao X, Chen X, Shuai K, Darnell JE Jr.

Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):3966-71. Epub 2005 Mar 7.

23.

Negative regulation of NF-kappaB signaling by PIAS1.

Liu B, Yang R, Wong KA, Getman C, Stein N, Teitell MA, Cheng G, Wu H, Shuai K.

Mol Cell Biol. 2005 Feb;25(3):1113-23.

24.

PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity.

Liu B, Mink S, Wong KA, Stein N, Getman C, Dempsey PW, Wu H, Shuai K.

Nat Immunol. 2004 Sep;5(9):891-8. Epub 2004 Aug 15.

PMID:
15311277
25.

PIASy-mediated repression of the androgen receptor is independent of sumoylation.

Gross M, Yang R, Top I, Gasper C, Shuai K.

Oncogene. 2004 Apr 15;23(17):3059-66.

PMID:
14981544
26.
27.

Regulation of JAK-STAT signalling in the immune system.

Shuai K, Liu B.

Nat Rev Immunol. 2003 Nov;3(11):900-11. Review. No abstract available.

PMID:
14668806
28.

Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.

Long J, Matsuura I, He D, Wang G, Shuai K, Liu F.

Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9791-6. Epub 2003 Aug 6.

29.

PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4.

Arora T, Liu B, He H, Kim J, Murphy TL, Murphy KM, Modlin RL, Shuai K.

J Biol Chem. 2003 Jun 13;278(24):21327-30. Epub 2003 Apr 25.

30.

Protein ISGylation modulates the JAK-STAT signaling pathway.

Malakhova OA, Yan M, Malakhov MP, Yuan Y, Ritchie KJ, Kim KI, Peterson LF, Shuai K, Zhang DE.

Genes Dev. 2003 Feb 15;17(4):455-60.

31.

Identification of a nuclear Stat1 protein tyrosine phosphatase.

ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, Zhu W, Tremblay M, David M, Shuai K.

Mol Cell Biol. 2002 Aug;22(16):5662-8.

32.

Induction of apoptosis by protein inhibitor of activated Stat1 through c-Jun NH2-terminal kinase activation.

Liu B, Shuai K.

J Biol Chem. 2001 Sep 28;276(39):36624-31. Epub 2001 Jul 12.

33.

A role for IL-12 receptor expression and signal transduction in host defense in leprosy.

Kim J, Uyemura K, Van Dyke MK, Legaspi AJ, Rea TH, Shuai K, Modlin RL.

J Immunol. 2001 Jul 15;167(2):779-86.

34.

Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells.

Gross M, Liu B, Tan J, French FS, Carey M, Shuai K.

Oncogene. 2001 Jun 28;20(29):3880-7.

35.

Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription.

Mowen KA, Tang J, Zhu W, Schurter BT, Shuai K, Herschman HR, David M.

Cell. 2001 Mar 9;104(5):731-41.

36.

A transcriptional corepressor of Stat1 with an essential LXXLL signature motif.

Liu B, Gross M, ten Hoeve J, Shuai K.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3203-7.

37.

The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3.

Rödel B, Tavassoli K, Karsunky H, Schmidt T, Bachmann M, Schaper F, Heinrich P, Shuai K, Elsässer HP, Möröy T.

EMBO J. 2000 Nov 1;19(21):5845-55.

38.

Modulation of STAT signaling by STAT-interacting proteins.

Shuai K.

Oncogene. 2000 May 15;19(21):2638-44. Review.

40.

Rapid gene repression triggered by interleukin-6 at the onset of monocyte differentiation.

Graeber TG, Shuai K.

Biochem Biophys Res Commun. 2000 Jan 27;267(3):863-9.

PMID:
10673382
41.

Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis.

Tan J, Hall SH, Hamil KG, Grossman G, Petrusz P, Liao J, Shuai K, French FS.

Mol Endocrinol. 2000 Jan;14(1):14-26.

PMID:
10628744
42.

The STAT family of proteins in cytokine signaling.

Shuai K.

Prog Biophys Mol Biol. 1999;71(3-4):405-22. Review.

PMID:
10354707
44.

Inhibition of Stat1-mediated gene activation by PIAS1.

Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K.

Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10626-31.

45.

IL-15 enhances the response of human gamma delta T cells to nonpeptide [correction of nonpetide] microbial antigens.

García VE, Jullien D, Song M, Uyemura K, Shuai K, Morita CT, Modlin RL.

J Immunol. 1998 May 1;160(9):4322-9.

46.

Specific inhibition of Stat3 signal transduction by PIAS3.

Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K.

Science. 1997 Dec 5;278(5344):1803-5.

48.

Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.

Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL.

Oncogene. 1996 Jul 18;13(2):247-54.

PMID:
8710363
49.

Disease-activated transcription factor: allergic reactions in human skin cause nuclear translocation of STAT-91 and induce synthesis of keratin K17.

Jiang CK, Flanagan S, Ohtsuki M, Shuai K, Freedberg IM, Blumenberg M.

Mol Cell Biol. 1994 Jul;14(7):4759-69.

50.

Interferon-activated signal transduction to the nucleus.

Shuai K.

Curr Opin Cell Biol. 1994 Apr;6(2):253-9. Review.

PMID:
8024817

Supplemental Content

Support Center